Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02124421
Title Outcomes in CRS/HIPEC as Initial Treatment of Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mercy Medical Center
Indications

ovarian cancer

fallopian tube cancer

peritoneum cancer

Therapies

Carboplatin + Paclitaxel

Cisplatin + Paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.